Open Label, Multicenter, Dose-Escalation/ Expansion Phase Ib Study to Evaluate Safety and Activity of BET Inhibitor RO6870810 (RO), Given As Monotherapy to Patients (pts) with Advanced Multiple Myeloma

Autor: Ramasamy, Karthik, Nooka, Ajay, Quach, Hang, Htut, Myo, Popat, Rakesh *, Liedtke, Michaela, Tuchman, Sascha A, Laubach, Jacob P., Gasparetto, Cristina, Chanan-Khan, Asher A., Hertzberg, Mark, Demario, Mark *, Nueesch, Eveline *, Chesne, Evelyne *, Franjkovic, Izolda *, Lechner, Katharina *, Kornacker, Martin, Cho, Hearn Jay
Zdroj: In Blood 5 November 2020 136 Supplement 1:12-14
Databáze: ScienceDirect